Clinical Trials Sponsored by Eicos Sciences, Inc.

Total 1395 results

Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Dynamics Among Semantic Dementia Patients

Semantic Dementia

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Atopic Dermatitis

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns Among Stage IV Melanoma Patients

Stage IV Melanoma

United States
Power Life Sciences Inc.

Not yet recruiting

A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study

Medullary Thyroid Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Lymphoma

Lymphoma

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

Follicular Lymphoma

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Merkel Cell Carcinoma

United States
Power Life Sciences Inc.

Not yet recruiting

Appraising Clinical Trial Experiences of Patients With Insomnia

Insomnia

United States
Power Life Sciences Inc.

Not yet recruiting

Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences

Chronic Fatigue Syndrome

United States
Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Glioblastoma Multiforme

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Depression

Depression

United States
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

Pulmonary Fibrosis

United States
Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials

Bipolar Disorder

United States
Power Life Sciences Inc.

Recruiting

Discovering Factors in the Clinical Study Journey of Patients With OCD

Obsessive-Compulsive Disorder | OCD

United States
Power Life Sciences Inc.

Not yet recruiting

An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research

Schizophrenia
Power Life Sciences Inc.

Not yet recruiting

Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients

Hairy Cell Leukemia
Power Life Sciences Inc.

Not yet recruiting

In Depth Observational Clinical Trial Of Retinitis Pigmentosa Patients

Retinitis Pigmentosa
Power Life Sciences Inc.

Not yet recruiting

Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research

Esophageal Cancer
Power Life Sciences Inc.

Not yet recruiting

Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences

Anaplastic Thyroid Cancer
Power Life Sciences Inc.

Not yet recruiting

Investigating Medical Research Trends in Osteoarthritis Clinical Trials

Osteoarthritis
Power Life Sciences Inc.

Not yet recruiting

Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences

Non-Small Cell Lung Cancer
Power Life Sciences Inc.

Not yet recruiting

Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences

Ulcerative Colitis
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Glioblastoma
Power Life Sciences Inc.

Not yet recruiting

Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials

Gastric Cancer
Power Life Sciences Inc.

Not yet recruiting

Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

Cholangiocarcinoma
Power Life Sciences Inc.

Not yet recruiting

Examining the Experiences of Brain Injury Patients in Medical Trials

Brain Injuries
TransThera Sciences (Nanjing), Inc.

Recruiting

A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies

B-Cell Malignancies

China
Kezar Life Sciences, Inc.

Recruiting

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

Autoimmune Hepatitis

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure

Congestive Heart Failure
Power Life Sciences Inc.

Not yet recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Cancer | Immunotherapy
Power Life Sciences Inc.

Not yet recruiting

Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients

Rheumatoid Arthritis

United States
TransThera Sciences (Nanjing), Inc.

Recruiting

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Gastric Cancer | Prostate Cancer | Cholangiocarcinoma | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Small-cell Lung Cancer | Thyroid Cancer | Biliary Tract Cancer | Gallbladder Cancer | HER2-negative Breast Cancer

China
TransThera Sciences (Nanjing), Inc.

Completed

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Fusion | FGFR1 Alteration | FGFR3 Alteration

United States
TransThera Sciences (Nanjing), Inc.

Available

Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors

Advanced Solid Tumors | Cholangiocarcinoma

United States
TriSalus Life Sciences, Inc.

Active, not recruiting

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma in the Liver

United States
Surgical Information Sciences Inc.

Completed

Accuracy Evaluation of SIS Software-based Visualization of New Anatomical Brain Structure

Software Evaluation for Visualizing Anatomical Structures Not Typically Identified on Clinical MR Images

United States
TransThera Sciences (Nanjing), Inc.

Completed

A Phase 1 Study of TT-00920 in Healthy Subjects

Healthy

China
TransThera Sciences (Nanjing), Inc.

Completed

Phase I, First-In-Human Study of TT-00920 in Healthy Subjects

Healthy

United States
Surgical Information Sciences Inc.

Terminated

SIS Evaluation of the MRI Defined Subthalamic Nucleus* (STN)

Deep Brain Stimulation

United States
Kezar Life Sciences, Inc.

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP (MARINA)

Immune Thrombocytopenia | Autoimmune Hemolytic Anemia

Poland, United States, Australia, Italy, Russian Federation
EtectRX, Inc.
Quotient Sciences

Completed

Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence

Healthy Volunteers

United States
Celtaxsys, Inc.
Quotient Sciences

Completed

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)

Heathy Volunteers

United Kingdom
Bioniche Life Sciences Inc.

Completed

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Bladder Neoplasms

Canada, United States
Telomerase Activation Sciences, Inc

Unknown

Effect of TA-65MD on Healthy Volunteers (TA-65MD)

Healthy

United States
Human Genome Sciences Inc.

Completed

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Germany, Hungary, Romania
Human Genome Sciences Inc.

Completed

Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic

United States, Canada
Human Genome Sciences Inc.

Completed

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

HIV Infections

United States
Human Genome Sciences Inc.

Completed

Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States

Clinical Trials Sponsored by Eicos Sciences, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations